Morgan Stanley Downgrades Genmab to Underweight, Announces $37 Price Target

Morgan Stanley analyst Matthew Harrison downgrades Genmab (NASDAQ:GMAB) from Equal-Weight to Underweight and announces $37 price target.

byBenzinga Newsdesk

September 7, 2021

1 minute read

Morgan Stanley analyst Matthew Harrison downgrades Genmab (NASDAQ:GMAB) from Equal-Weight to Underweight and announces $37 price target.

RespireRx Signs LOI With Australian CRO For Dronabinol Development For Obstructive Sleep Apnea

By Vuk Zdinjak

November 17, 12:21 PM

RespireRx Pharmaceuticals Inc. (OTCPK:RSPI) entered into a letter of intent with an Australia headquartered bespoke clinical research organization focused on cannabinoid and psychedelic clinical research.

RSPI

Burlington Stores, Oracle, Nutanix Are Among Top 10 Large Cap Losers Last Week (Nov. 24-Nov. 28): Are the Others in Your Portfolio?

By Nabaparna Bhattacharya

November 30, 2:01 PM

Nutanix, Burlington Stores, Oracle and other major names led last week's steepest large-cap stock declines, driven by weak results and analyst downgrades.

ACM

Bitcoin Is Once Again Ahead Of Facebook In Market Capitalization After Latter’s 26% Plunge

By Shivdeep Dhaliwal

February 3, 11:10 PM

Bitcoin (CRYPTO: BTC) has surpassed Facebook parent Meta Platforms Inc (NASDAQ: FB) in value once again.

AAPL

Mid-Morning Market Update: Markets Open Higher; Coca-Cola Tops Q2 Views

By Lisa Levin

July 21, 10:47 AM

Following the market opening Wednesday, the Dow traded up 0.62% to 34,727.53 while the NASDAQ rose 0.40% to 14,557.04. The S&P also rose, gaining 0.52% to 4,345.65.

AMPY

Morgan Stanley Downgrades Genmab to Underweight, Announces $37 Price Target

Related Posts

RespireRx Signs LOI With Australian CRO For Dronabinol Development For Obstructive Sleep Apnea

Burlington Stores, Oracle, Nutanix Are Among Top 10 Large Cap Losers Last Week (Nov. 24-Nov. 28): Are the Others in Your Portfolio?

Bitcoin Is Once Again Ahead Of Facebook In Market Capitalization After Latter’s 26% Plunge

Mid-Morning Market Update: Markets Open Higher; Coca-Cola Tops Q2 Views